GlassScriptPhysician profile
Kelli Nowak
NPI 1255760443
$4,397.03
in general payments reported to CMS, 2019-2025
24 companies · $817 in 2025
The $817 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,083 · 2022: $773 · 2023: $851 · 2024: $874 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442 · Education: $99.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.61 |
| Education | $99.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $711.24 | 2022-2025 | |
| Abbvie INC. | $690.79 | 2021-2023 | |
| Therapeuticsmd, INC. | $436.23 | 2021-2022 | |
| Astellas Pharma US INC | $416.23 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $293.39 | 2024-2025 | Slynd |
| Sumitomo Pharma America, INC. | $280.35 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $210.28 | 2021-2022 | |
| Agile Therapeutics, INC. | $205.01 | 2021-2024 | Twirla |
| Sage Therapeutics, LLC | $187.55 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $174.63 | 2021-2024 | Injectafer |
| Shield Therapeutics INC | $162.90 | 2023-2025 | Accrufer |
| Pfizer INC. | $122.84 | 2021-2023 | |
| Organon LLC | $85.71 | 2022-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $84.12 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $75.59 | 2021-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $62.63 | 2021-2022 | |
| Qiagen, LLC | $43.32 | 2022-2023 | |
| Optumhealth Care Solutions, LLC | $31.46 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $25.01 | 2023 | Paragard T 380a |
| Dexcom, INC. | $24.19 | 2024 | Dexcom G6 Transmitter |
| Scynexis, INC. | $21.55 | 2022 | |
| Millicent US INC | $20.59 | 2025 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $18.47 | 2021 | |
| Medicem INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Nowak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.